Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis
Hypertension and hypercholesterolemia are independent risk factors for atherosclerotic cardiovascular disease (ASCVD) by acting directly on the endothelium and activating the renin-angiotensin aldosterone system (RAAS) and mevalonate pathways. This review examines how the severity and duration of these risk factors may influence the cardiovascular risk through a reciprocal interplay leading to oxidative stress and pro-inflammatory response.
Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - Category: Nutrition Authors: Claudio Borghi, Bernard I. Levy Tags: Viewpoint Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Heart | Hypertension | Nutrition | Statin Therapy